[cctv.com] national organization drug centralized procurement pilot landing government departments do not directly participate in procurement

Beijing, Feb 8 (reporter Jiang Yong) according to the voice of economy "Tianxia finance and economics", in the past year, the newly established national health insurance bureau has sent many red envelopes to the vast number of patients through a series of reforms, for example, the number of cross provincial and non local medical institutions has exceeded 15000, 17 kinds of anti-cancer drugs have been included in the medical insurance, reducing the drug cost burden for patients by more than 75% State health insurance bureau: the government departments are not directly involved in drug procurement The notice of the general office of the State Council on printing and distributing the pilot program of centralized drug procurement and use organized by the state was recently released, which marks that the centralized drug procurement and use in 11 cities such as Shanghai and Beijing have entered the implementation stage, and the market and society pay high attention to this key reform Many people vividly compare the centralized purchase of drugs to the "national drug group purchase" However, Zhong Dongbo, director of the price bidding and Purchasing Department of the state health insurance bureau, said in an exclusive interview with the voice of economy that although the metaphor is image, it is not very accurate In this process, the government department only plays the role of any organizer and does not directly participate in the drug purchase Zhong Dongbo said that at the national level, only the policy scope and requirements have been formulated, which has played an organization driven role The main body of centralized procurement is still public medical institutions and their representatives in 11 cities Therefore, procurement is actually a market transaction behavior The procurement institutions follow the principles of openness, fairness and fairness to carry out group procurement, and the enterprises are also willing to participate in fair competition In the end, according to the spirit of commercial contract, a transaction is formed and a purchase and sale contract is signed The state plays a role in building a system, setting up a platform and promoting docking Reducing drug prices is just one of the targets In December last year, 11 pilot cities, including Shanghai and Beijing, officially announced the results of the selection of drugs for centralized procurement There were 25 drugs selected, with the average price reduction of 52% and the maximum reduction of more than 90% Zhong Dongbo said that reducing drug prices is only one of the goals of the state organization for centralized drug procurement He said: "first, the bidding procurement emphasizes the safety and quality, and takes the drugs that pass the consistency evaluation of national drug efficacy and quality as the quality threshold, which can improve the quality of drug use in medical institutions; second, make the price of drugs significantly lower, further reduce the burden of drug costs of the masses; third, let the masses get more standardized and reasonable prescription drug services The obvious drop in drug prices has squeezed out the space for the original sales with gold in the middle Therefore, if there is no space for medical enterprises to give kickbacks to doctors, our medical staff can have a reasonable diagnosis and medication " The centralized purchase of drugs is conducive to the development of the purification industry It is worth noting that the centralized purchase of drugs organized by the state also has a linkage effect in reducing the drug price As the price of the winning drugs drops sharply, it is difficult for the drugs with the same pharmacological effect to maintain the original price level Some non winning drug companies have chosen to reduce the price For example, the price of gefitinib produced by Qilu Pharmaceutical Co., Ltd has been adjusted from 1585 yuan to 498 yuan, a drop of about 69% Zhong Dongbo said that since the centralized procurement of drugs organized by the state strictly requires the integration of bidding and purchasing, and the implementation of "procurement with quantity", this solves the problems in the process of bidding and purchasing of drugs in the past, such as uncoupling of quantity and price, inconsistency of bidding and purchasing, and "sales with gold" In the long run, this is conducive to purifying the development ecology of the industry and promoting the healthy development of the pharmaceutical industry Zhong Dongbo said that the centralized procurement of drugs organized by the state can purify the ecology of the pharmaceutical industry, promote the transformation and upgrading of the pharmaceutical industry, and promote the high-quality development of the pharmaceutical industry After that, there will be two kinds of enterprises gradually One is an enterprise focusing on R & D and innovation, which can have innovative drugs and can obtain high-end profits and high returns The second is generic drugs, which must have a higher level of technology to ensure the efficacy of drugs The key to the success or failure of the pilot drug centralized purchase is to ensure the quality and quantity of the selected drugs to be used by the patients The industry believes that the key to the success or failure of the pilot drug centralized purchase organized by the state is to ensure the quality and quantity of the selected drugs to be used by the patients, which requires the medical insurance bureau and the National Health Commission to carry out relevant supervision work Zhang Zongjiu, director of the medical administration bureau of the national health and Health Commission, previously disclosed that in order to ensure the access of selected drugs to medical institutions, he would put forward requirements for health departments and medical institutions: the reasonable use and supply of selected drugs should not be affected by the requirements of cost control, drug proportion and quantity of drug regulations of medical institutions; public medical institutions should be required to optimize the drug use structure to ensure the optimal use under the same conditions First, select the selected drugs; the health department should strengthen the guidance and supervision of public medical institutions, and urge public medical institutions to purchase and use the selected drugs in priority according to the agreed purchase volume.